Nutra Pharma has provided a response to the FDA warning letter sent to the company on March 11, 2019 regarding Nutra Pharma’s homeopathic drug, Nyloxin®. April 10, 2019 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that the Company has responded to an FDA warning letter that was issued on March 11th regarding the company’s we